Omnicell, Inc. (OMCL) |
29.945 -1.175 (-3.78%) 10-10 11:51 |
Open: | 31.03 |
High: | 31.48 |
Low: | 29.6 |
Volume: | 57,478 |
Market Cap: | 1,376(M) |
PE Ratio: | 59.89 |
Exchange: | NASDAQ Global Select |
Industry: | Medical - Healthcare Information Services |
Sector: | Healthcare |
Technical analysis | ||||
![]() |
||||
sell | buy |
Resistance 2: | 33.32 |
Resistance 1: | 31.83 |
Pivot price: | 30.70 |
Support 1: | 29.43 |
Support 2: | 24.49 |
52w High: | 55.75 |
52w Low: | 22.66 |
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California.
EPS | 0.500 |
Book Value | 27.220 |
PEG Ratio | 0.00 |
Gross Profit | 10.983 |
Profit Margin (%) | 2.01 |
Operating Margin (%) | 2.80 |
Return on Assets (ttm) | 0.5 |
Return on Equity (ttm) | 1.9 |
Fri, 10 Oct 2025
Omnicell (NASDAQ:OMCL) Given Sell (D+) Rating at Weiss Ratings - MarketBeat
Tue, 07 Oct 2025
Is Omnicell (OMCL) Stock Undervalued Right Now? - sharewise.com
Tue, 07 Oct 2025
Reasons to Add Omnicell Stock to Your Portfolio Right Now - sharewise.com
Mon, 06 Oct 2025
Omnicell to Release Third Quarter 2025 Financial Results on October 30, 2025 - Business Wire
Mon, 06 Oct 2025
Hunter Perkins Capital Management LLC Buys Shares of 9,370 Omnicell, Inc. $OMCL - MarketBeat
Tue, 30 Sep 2025
Omnicell, Inc. (NASDAQ:OMCL) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
![]() StockChart iOS |
![]() StoxlineLite iOS |
![]() StoxlineLite iOS |
![]() OptionCalc iOS |
![]() StockChart Android |
![]() StoxlineLite Android |
![]() StoxlinePro Android |
![]() OptionCalc Android |